Form 4: Rocket Pharmaceuticals' General Counsel Sells Shares to Cover Tax Obligations

Martin Wilson, General Counsel of Rocket Pharmaceuticals, sold 1,027 shares of common stock on August 16, 2024, to cover tax withholding obligations related to vesting RSUs.

Summary

• On August 16, 2024, Martin Wilson, the General Counsel of Rocket Pharmaceuticals, sold 1,027 shares of the company's common stock.
• The sale was executed at a price of $18.504 per share.
• The purpose of the sale was to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
• Following the transaction, Wilson directly owns 64,735 shares of Rocket Pharmaceuticals' common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transaction is a routine sale of shares to cover tax obligations, which is a common practice and doesn't necessarily reflect a positive or negative outlook on the company.

Industry Context

Sales of shares to cover tax obligations upon vesting of RSUs are a common practice among company executives and are generally not indicative of a negative outlook on the company's future.

Stakeholder Impact

• The sale has a minimal impact on shareholders as it's a small transaction by an individual officer to cover tax obligations.

Key Dates